Recombinant human erythropoietin (China Resources Angde Biotech Pharma)
重组人促红素（华润昂德生物药业）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human erythropoietin (China Resources Angde Biotech Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2003/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChina Resources Angde Biotech Pharma Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesChina Resources Angde Biotech Pharma Co Ltd
Inactive CompaniesAngde Biotech Pharmaceutical Co Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A